Artivion | CRY - Current Assets


Artivion reported $358.08M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Accuray USD 303.6M 13.86M Sep/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 358.08M 20.58M Dec/2025
AtriCure USD 322.52M 21.41M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Inogen USD 203.72M 594K Sep/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Orthofix International USD 416.85M 22.68M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
ResMed USD 3.82B 193.06M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Surmodics USD 75.99M 5.31M Jun/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Terumo JPY 815.56B 71.48B Dec/2025
Trinity Biotech USD 35.52M 2.52M Sep/2025